Core Viewpoint - The recent penalties imposed by the Shandong Securities Regulatory Bureau on Lide Capital Management Co., Ltd. reveal serious violations including false advertising, promises of capital protection and returns, misappropriation of fund assets, and operating a fund pool business, indicating a complete failure in governance and management responsibility within the organization [1][2][3] Summary by Relevant Sections Violations and Regulatory Actions - Lide Capital was found to have committed 12 violations in its private fund operations, covering key areas such as promotional activities, investor protection, fundraising, qualification review, contract signing, fund management, document preservation, and information disclosure [2][3] - The Shandong Securities Regulatory Bureau mandated Lide Capital to rectify these issues and submit a written report within 30 days of receiving the decision [2] - Li Xingchun, the former legal representative and chairman of Lide Capital, was held primarily responsible for these violations and received a warning from the regulatory authority [2] Company Background and Structure - Lide Capital is a wholly-owned subsidiary of Lide Technology Co., Ltd., which has a significant presence in the asset management industry with over 200 billion yuan in managed and serviced assets [3][5] - The company has been expanding rapidly through a "full license" strategy, but its compliance and risk control capabilities have not kept pace with this growth [5] Compliance and Governance Issues - Lide Capital and its associated private equity firms lack designated compliance and risk control personnel, highlighting significant governance deficiencies within the "Lide system" [1][6] - The absence of compliance leadership reflects a broader issue of insufficient regulatory enforcement and oversight, particularly regarding the separation of registration and operational locations [6][8] Industry Context and Future Outlook - The private equity industry is undergoing a phase of accelerated cleansing due to stricter regulations, with weaker and non-compliant firms likely to be phased out [8] - Recommendations for enhancing compliance management in the private equity sector include establishing mandatory compliance roles, improving information disclosure, and leveraging technology for real-time monitoring of fund flows and compliance risks [8]

浙江久兴投资管理有限公司董事长，以独特投资策略纵横A股十余年，虽 然刚进入私募基金行业2年时间，便已获得包括证券时报2024年金长江年 度新锐私募基金经理，私募排排网2024年度十佳基金经理，西南证券首届 私募实盘大赛年度荣誉金鼎奖在内的多项行业权威奖项。 7 月 4 日 -5 日，【 格隆汇中期策略峰会 2025 】将在深圳拉开帷幕。 在两天的会期里将分别举办 2025 年格隆汇中期策略会、全球机构投资者思享会、"格隆汇金格 奖" ESG 卓越榜单发布、数十家上市公司路演汇等活动。 其中，全球机构投资者思享会作为峰会的重要组成部分，将邀请市场表现优异的顶级二级市场投 资人，分享其独到的投资策略和理念，同时分享其对下半年投资方向和路径的看法，为投资者锚 定航向。 本次全球机构投资者思享会我们非常荣幸的邀请到了久兴投资董事长 —— 王玺先生 莅临现 场！ 嘉宾介绍 王玺 2024年度5-10亿规模组十佳基金经理 （数据来源：私募排排网） 价，原价 1 088/ 人）， 限前 7 2 位！ 普通席位 388/ 人（早鸟价，原价 688/ 人） 名额 200 人 ，先到先得！ 请联系专属客服购买票！ 星火汇聚，终成 ...

Core Viewpoint - Macro strategy, based on macroeconomic analysis for asset allocation, has shown better investment performance during economic cycles, gaining increasing attention in recent years [2] Group 1: Macro Strategy Performance - In mature overseas markets, macro strategy is recognized as a core strategy for hedge funds, particularly excelling during market volatility, as exemplified by Bridgewater's Pure Alpha II, which rose approximately 11.3% in 2025 while the S&P 500 fell over 5% [2] - In the domestic market, macro strategy is still in its early stages but has been developing rapidly, with 131 macro strategy products showing performance in the last six months [2] - Although the average return for macro strategies was negative in May, the long-term performance is impressive, with an average return of 45.67% over the past three years, ranking fourth among all secondary strategies [2][3] Group 2: Performance Rankings - The top 20 macro strategy products in the last six months had a minimum return threshold of ***%, with an average return of ***% [4] - Notable products include "Luyuan Ruize Stable Growth" from Luyuan Private Equity, "Yize Global Macro No. 2" from Yize Investment, and "Duration Macro Multi-Strategy" from Duration Investment, which ranked in the top three [4][8] - Three products from billion-dollar private equity firms made the list, including "Honghu Stable Macro Hedge A" from Honghu Private Equity and "Lerui Stock-Bond Rotation No. 1" from Lerui Asset [4] Group 3: Yearly and Three-Year Performance - The top 20 macro strategy products over the past year had a minimum return threshold of ***%, with the top three being "Shenzhen Shanzhe Private Equity," "Duration Investment," and "Luyuan Private Equity" [9][13] - Over the past three years, the top 20 macro strategy products had a minimum return threshold of ***%, with "Luyuan Ruize Stable Growth" again leading the list [15][19] - The consistent performance of "Luyuan Ruize Stable Growth" across both six-month and three-year periods highlights its strong investment strategy [15]

Core Viewpoint - The article provides an overview of the private equity market in China, highlighting the number of private equity firms, their performance, and the distribution of firms across major cities as of May 2025. Group 1: Overview of Private Equity Firms - As of May 2025, there are 7,789 private equity firms in China, with 5,616 located in first-tier cities (Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou), accounting for 72.10% of the total [2]. - The number of top-tier private equity firms (with assets over 5 billion) is highest in Shanghai (86 firms), followed by Beijing (47 firms) and Shenzhen (18 firms) [2]. Group 2: Performance Metrics by Region - In Beijing, 582 products have an average annual return of 21.30% and a May return of 1.74% [4]. - Shanghai's 1,145 products show an average annual return of 19.68% and a May return of 1.68% [13]. - Guangzhou's 228 products have an impressive average annual return of 28.40% and a May return of 3.28% [19]. - Shenzhen's 705 products yield an average annual return of 23.55% and a May return of 3.81% [24]. - Hangzhou's 268 products report an average annual return of 26.06% and a May return of 2.01% [31]. Group 3: Notable Private Equity Firms - In Beijing, the top private equity firms include "止于至善投资" with a notable annual return and several other firms with significant assets [6][9]. - In Shanghai, "海南致衍私募" leads with a strong performance, followed by "系综(上海)私募" and "上海紫杰私募" [12][16]. - In Guangzhou, "海南香元私募" ranks first with a high annual return, followed by "广州千泉私募" and "广州守正用奇" [19][21]. - In Shenzhen, "富延资本" is the top firm with a strong performance, followed by "能敬投资控股" and "君子乾乾" [27][29]. - In Hangzhou, "云起量化" leads the performance metrics, followed by "浩坤昇发资产" and "橡木资产" [35]. Group 4: Other Regions - Outside first-tier cities, there are 2,173 private equity firms, with 25 firms having assets over 5 billion [36][39]. - The average annual return for 972 products in other regions is 23.24%, with the top three firms being "一久私募基金," "尚阳资管," and "优波资本" [39].

Core Insights - The A-share market has shown significant structural characteristics this year, with a volatile market environment and rapid sector rotation providing an ideal operating soil for index enhancement (referred to as "指增") strategies [1] - Private equity fund industry index enhancement products have performed well, demonstrating strong excess return capabilities, with an average annual return of 10.59% and an average excess return of 11.92% for 682 products in the first five months [1][2] Market Environment - The market style has shifted towards small-cap stocks, which benefits quantitative index enhancement strategies that have a natural advantage in small-cap stock allocation [1] - High market liquidity has created favorable conditions for index enhancement strategies, expanding the range of investable targets and significantly reducing transaction costs [1] Product Performance - Among the 128 index enhancement products based on the CSI 1000 index, the average excess return was 10.95%, with 97.66% of products achieving positive excess returns, leading to an average return of 12.24% [2] - In contrast, the 197 products based on the CSI 500 index had an average excess return of 10.25%, but due to a decline in the index, the average return was only 9.20% [2] - The CSI 300 index enhancement products performed the weakest, with an average return of only 2.49% [2] Management Scale Insights - Large private equity firms (with assets under management over 5 billion yuan) showed a clear advantage in index enhancement strategies, achieving an average excess return of 12.86% across 254 products, with nearly 100% achieving positive excess returns [3] - Smaller private equity firms (under 1 billion yuan) also found opportunities in specific areas, with 40 products achieving excess returns over 20%, and one even reaching 70.07% [3] - Medium-sized private equity firms (1 billion to 5 billion yuan) maintained a balance of stability and flexibility, with 96.69% of their products achieving positive excess returns [3] Competitive Advantages - Large institutions leverage resource advantages, including strong technical research investments, specialized research teams, and high market recognition, which enhance strategy execution efficiency [4] - Future competition among private equity index enhancement products is expected to focus on data mining depth, trading execution precision, and risk control capabilities [4]

Group 1 - The private equity industry is witnessing a trend of limiting new client subscriptions, signaling a strategic shift towards managing fund sizes to protect existing investors' interests [2][3][4] - Quantitative private equity firms, such as Yuanfu Investment and Longqi Technology, have announced plans to close certain products to new investors, while allowing existing clients to continue investing [2][3] - The rationale behind these actions includes preventing dilution of investment returns and ensuring that fund managers can maintain performance amid market volatility [4][5] Group 2 - The trend of limiting subscriptions reflects a cautious approach by private equity firms in response to current market uncertainties, indicating a focus on long-term performance rather than rapid growth [5][6] - Recent data shows that retail investor sentiment is improving, with significant net inflows into the A-share market, suggesting a potential recovery in market conditions [6][7] - Private equity firms are increasingly focusing on sectors such as semiconductors and medical devices, with a notable increase in research activity in these areas [10][11]

Core Viewpoint - The article discusses the performance and popularity of quantitative private equity firms and their managers in the A-share market as of May 2025, highlighting the top firms and their recent returns [2][3][4]. Group 1: Popular Quantitative Private Equity Firms - The top three popular quantitative private equity firms are Liantai Investment, Ningbo Huafang Quantitative, and Hainan Shengfeng Private Equity [3][4]. - Among the top 20 firms, 17 have a scale of over 10 billion, indicating a concentration of larger firms in popularity [3]. - The firms listed have shown varying performance over the past six months and one month, with specific returns not disclosed due to regulatory requirements [6][9]. Group 2: Popular Quantitative Fund Managers - The top five fund managers in popularity are Wang Yiping, Lin Ziyang, Sun Lin, Liu Yang, and He Chun, with a mix of experience and backgrounds [11][12]. - Wang Yiping from Evolutionary Assets leads in both popularity and performance, managing ten products with significant returns [16]. - Lin Ziyang from Hainan Shengfeng Private Equity ranks second, managing eleven products with notable performance [10][12]. Group 3: Popular Quantitative Private Equity Products - The top five popular products include those managed by Wang Yiping, Lin Ziyang, and others, with a focus on quantitative long strategies [18][19]. - The products listed have shown strong performance metrics, although specific return figures are not disclosed [20][23]. - The popularity of these products reflects the effectiveness of quantitative strategies in the current market environment [18][19].

证券代码：001330 证券简称：博纳影业 公告编号：2025-034 号 博纳影业集团股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、与专业投资机构共同投资概述 公司将严格按照相关规定，根据本基金的后续进展情况及时履行信息披露义 务。敬请广大投资者理性投资，注意投资风险。 四、备查文件 《私募投资基金备案证明》 特此公告 博纳影业集团股份有限公司 董事会 博纳影业集团股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日召开第 三届董事会第十五次会议，审议通过了《关于全资子公司与专业投资机构共同投 资的议案》，同意全资子公司天津博纳企业管理咨询有限公司（以下简称"天津企 管"）作为有限合伙人，以自有资金出资人民币 99,900 万元，与专业投资机构光 合（海南）私募基金管理有限公司（以下简称"光合私募"）共同投资嘉兴光影智 趣股权投资合伙企业（有限企业）。具体内容详见公司于 2025 年 4 月 29 日在《中 国 证 券 报 》《 证 券 时 报 》《 上 海 证 券 报 》《 证 券 日 报 》 和 巨 潮 资 讯 网 （w ...

Core Viewpoint - The article emphasizes the long-term performance and risk management strategies of Nanjing Chiying Private Fund Management Co., which focuses on futures market investments and aims for sustainable wealth growth while ensuring capital safety [2][5]. Company Overview - Nanjing Chiying was established in 2007 and is one of the first private fund teams in China to collaborate with public funds [2]. - The company has a strong emphasis on rational investment and risk control, with a track record of positive returns on all completed products since the 2012 privatization of futures private equity [5][6]. Performance Highlights - The company has achieved a continuous performance curve with a stair-step growth pattern over 20 years [5]. - All completed products have yielded positive returns, with a total of 15 products managed and 12 completed successfully [7]. Core Team - The core team consists of five members with over 20 years of experience in the futures market, combining deep market understanding with practical trading experience [6][7]. - The team is led by Qian Jun, who has a background in investment management and has been with the company since its inception [6]. Competitive Advantages - The company employs a comprehensive risk control system, prioritizing capital safety over potential opportunities [5][7]. - It focuses on absolute returns and has a high compound annual growth rate, demonstrating significant compounding effects [7]. - The investment strategy includes a dynamic approach to profit locking and risk management, ensuring a balance between capturing trends and protecting investor capital [7]. Product Strategy - The main strategy involves a subjective CTA trend-following approach, which captures complete trends to maximize returns [7]. - The strategy includes low-risk trial positions, dynamic profit locking, and a focus on maximizing trend capture without preemptively predicting market tops or bottoms [7]. Recent Developments - The company rebranded to Nanjing Chiying Private Fund Management Co. in 2023 and has plans for new product launches in collaboration with private fund platforms [6][9].

6月18日，中国证监会主席吴清在2025陆家嘴论坛上表示，更大力度培育壮大耐心资本、长期资本，聚 焦私募基金"募投管退"各环节卡点堵点，精准发力、畅通循环。积极推动社保基金、保险资金、产业资 本参与私募股权投资，拓宽资金来源。(人民财讯) ...